论文部分内容阅读
目的 探讨米索前列醇(简称米索)对第3产程和产后2h内出血量的影响。方法 选择观察组120例产妇,分别分为单纯用米索者60例,于胎儿出后立刻口服米索前列醇3片(600μg);用米索加催产素者60例,米索用法同前,并于胎儿娩出时立即静脉注射催产素10u。对照组60例,单纯于胎儿娩出时立即静脉注射催产素10u。结果 米索组与米索加催产素组比较第3产程时间及产后2h内失血量无显著性差异(P>0.05);而米索组与催产素组比较第3产程时间及产后2h内失血量有显著性差异(P<0.05)。结论 米索前列醇比催产素有更强的宫缩作用。防治产后出血,安全、高效、简便,是较好的预防产后出血药物。
Objective To investigate the effect of misoprostol (referred to as misoprostol) on the amount of bleeding in the third stage of labor and 2 hours after delivery. Methods A total of 120 maternal women in the observation group were divided into three groups: 60 cases of Misoprostol alone and 3 tablets of misoprostol (600μg) orally immediately after the fetus. Sixty cases of misoprostol were treated with misoprostol , And intravenous oxytocin 10u immediately after the fetus was delivered. The control group of 60 patients, intravenous injection of oxytocin 10u simply when the fetus was delivered. Results There was no significant difference in blood loss between MISO group and misoprostol oxytocin group during the 3rd stage of labor and within 2 hours after delivery (P> 0.05), while the third stage of labor and the blood loss within 2 hours after delivery were lower in the misoprostol group and the oxytocin group There was a significant difference (P <0.05). Conclusions Misoprostol has a stronger contractile effect than oxytocin. Prevention and treatment of postpartum hemorrhage, safe, efficient and simple, is better prevention of postpartum hemorrhage drugs.